Skip to main content

Table 4 Studies describing in-hospital mortality in patients with resistant and multidrug-resistant Pseudomonas aeruginosa infections – cause of death identified specifically as Pseudomonas aeruginosa infection

From: Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

Setting Author Study groups (n) Infection-related In-Hospital Mortality P-value Ref
Tertiary Care Center Cao et al MDR P. aeruginosaa (44) 45.5% <0.05 [57]
Susceptible P. aeruginosa (68) 7.4%
Hirakata et al blaIMP-positive P. aeruginosa (69) 5.8% 0.02 [69]
blaIMP-negative P. aeruginosa (247) 1.2%
Tam et al MDR P. aeruginosab (25) 52% <0.001 [13]
Susceptible P. aeruginosa (84) 9.5%
  1. aAbsence of susceptibility to three or more antibiotics: ceftazidime, cefepime, piperacillin, ciprofloxacin, gentamicin, and imipenem or meropenem; bAbsence of susceptibility to three or more of the following four classes of agents: antipseudomonal carbapenems, antipseudomonal β-lactams (penicillins and cephalosporins), aminoglycosides, and fluoroquinolones.